Vimarsana
Biggest News Aggregation in the World

Page 12 - Ar T News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ar T. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ar T Today - Breaking & Trending Today

This Dodge Challenger R/T Three-Door Shooting Brake Isn't Real, Unfortunately - Vimarsana News

This Dodge Challenger R/T Three-Door Shooting Brake Isn't Real, Unfortunately

One of the main reasons why pony and muscle cars have survived through trial and tribulation since the sunset of their classic golden era is not just the...

Astellas and Poseida Therapeutics Announce Strategic Investment to Support Poseida's Commitment to Redefining Cancer Cell Therapy - Vimarsana News

Astellas and Poseida Therapeutics Announce Strategic Investment to Support Poseida's Commitment to Redefining Cancer Cell Therapy

Poseida is a clinical-stage biotechnology company dedicated to advancing a new class of cancer cell therapy and gene therapy products using genetic engineering technologies Astellas to invest a total of $50 million to acquire approximately 8.8% of Poseida and to receive a right of exclusive negotiation and first refusal for any potential partnering of P-MUC1C-ALLO1, an allogeneic CAR-T cell therapy product candidate for solid tumors Astellas will have the right to designate an obser...

Tim Scott does Mr. T impersonation on Fox News: 'I pity the fool!' - Vimarsana News

Tim Scott does Mr. T impersonation on Fox News: 'I pity the fool!'

Sen. Tim Scott (R-S.C.), a 2024 Republican presidential candidate, did his best impression of celebrity icon and actor Mr. T during a Fox News interview Thursday. Fox host Neil Cavuto mentioned to Scott that he did some background research, finding out the South Carolina Republican was a huge fan of “Rocky III.” “Tell me that…

Source: yahoo.com
ESMO Helps Hematologists Assess New Cancer Drugs - Vimarsana News

ESMO Helps Hematologists Assess New Cancer Drugs

The European Society for Medical Oncology has released a tool to help hematologists evaluate the magnitude of clinical benefit expected from new blood cancer treatments.

CAR T-Cell Therapy May Treat Antisynthetase Syndrome - Vimarsana News

CAR T-Cell Therapy May Treat Antisynthetase Syndrome

In a case study, a patient with refractory antisynthetase syndrome with progressive myositis and interstitial lung disease showed significant improvement in 8 months after CAR T-cell therapy.